Expression of Gprk2Scer\UAS.cFa under the control of Scer\GAL4mat.αTub67C.T:Hsim\VP16 does not severely affect ventral furrow closure, although it partially inhibits apical constriction.
Gprk2UAS.cFa, Scer\GAL4VP16.mat.αTub67C is a suppressor | partially of partially lethal phenotype of Scer\GAL4VP16.mat.αTub67C, ctaUAS.cFa
Gprk2UAS.cFa, Scer\GAL4VP16.mat.αTub67C is a suppressor | partially of embryo | embryonic stage 6 phenotype of Scer\GAL4VP16.mat.αTub67C, ctaUAS.cFa
Gprk2UAS.cFa, Scer\GAL4VP16.mat.αTub67C is a suppressor | partially of ventral furrow phenotype of Scer\GAL4VP16.mat.αTub67C, ctaUAS.cFa
Gprk2UAS.cFa, Scer\GAL4VP16.mat.αTub67C is a non-suppressor of embryo | embryonic stage 6 phenotype of Scer\GAL4VP16.mat.αTub67C, ctaQ303L.UAS
Expression of Gprk2Scer\UAS.cFa largely suppresses the gastrulation defects and semi-lethality seen when ctaScer\UAS.cFa is expressed under the control of Scer\GAL4mat.αTub67C.T:Hsim\VP16.
Expression of Gprk2Scer\UAS.cFa does not suppress the embryonic defects seen when ctaQ303L.Scer\UAS is expressed under the control of Scer\GAL4mat.αTub67C.T:Hsim\VP16.